Skip to content

To study the Minimum Effective Dose required to block the Selective truncal brachial plexus for elbow and forearm surgeries.

Selective truncal injection brachial plexus block for elbow and forearm surgeries- A dose finding study. - NIL

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/07/091506
Enrollment
50
Registered
2025-07-23
Start date
Unknown
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: S50-S59- Injuries to the elbow and forearm

Interventions

Intervention1: SELECTIVE TRUNCAL INJECTION BRACHIAL PLEXUS BLOCK FOR ELBOW AND FOREARM SURGERIES- A DOSE FINDING STUDY: In this study, Under USG guidance block is performed using the drug 0.5% bupiv

Sponsors

Ballari institute of Medical Sciences and Research centre Ballari
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Adult patients aged between 18 and 65 years 2 Scheduled for elective upper limb surgery requiring brachial plexus block 3 Classified as American Society of Anesthesiologists (ASA) physical status I to III 4 Willing and able to provide written informed consent 5 Cooperative and able to communicate effectively during the procedure

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Success rate of Surgical Block MEV90 estimationTimepoint: Block is assessed every 5 minutes till 40 min 0min 5 min 10 min 15 min 20 min 25 min 30 min 35 min 40 min

Secondary

MeasureTime frame
Sensory block onset time Motor Block Onset Time Duration of sensory and motor block Patient satisfaction scoreTimepoint: It is assessed for 40min after block and before incision

Countries

India

Contacts

Public ContactDr P Madhushree

Ballari institute of Medical Sciences and Research centre

nkiranchand@yahoo.com9845857056

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026